|
2022 Conference Publication Cost-benefit of pre-treatment dihydropyrimidine dehydrogenase genotyping to individualise fluoropyrimidine-based chemotherapy in a contemporary Australian settingKim, Hansoo, Kulasegaran, Tivya, Eastgate, Melissa, Wyld, David, Burge, Matthew and Nalder, Mark (2022). Cost-benefit of pre-treatment dihydropyrimidine dehydrogenase genotyping to individualise fluoropyrimidine-based chemotherapy in a contemporary Australian setting. HOBOKEN: WILEY. |
|
2022 Conference Publication Appendiceal neuroendocrine tumours in individuals under the age of 50 years: A population-based study from Queensland, AustraliaMoorhead, William, Youl, Philippa, Moore, Julie and Wyld, David (2022). Appendiceal neuroendocrine tumours in individuals under the age of 50 years: A population-based study from Queensland, Australia. HOBOKEN: WILEY. |
|
2022 Conference Publication Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: <SUP>177</SUP>Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) and capecitabine plus temozolomide (CAPTEM) for pancreas and midgut neuroendocrine tumours (pNETS, mNETS)-Final resultsPavlakis, Nick, Ransom, David Turner, Wyld, David, Sjoquist, Katrin Marie, Wilson, Kate, Gebski, Val, Murray, James, Kiberu, Andrew Ddembe, Burge, Matthew E., Macdonald, William, Roach, Paul, Pattison, David A., Butler, Patrick, Price, Timothy Jay, Michael, Michael, Lawrence, Benjamin James, Bailey, Dale L., Leyden, Simone, Zalcberg, John Raymond and Turner, Harvey (2022). Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) and capecitabine plus temozolomide (CAPTEM) for pancreas and midgut neuroendocrine tumours (pNETS, mNETS)-Final results. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2022 Conference Publication Salvage 177Lu-dotatate therapy in patients with progressive metastatic neuroendocrine tumorsHoe, Hui Jing and Wyld, David (2022). Salvage 177Lu-dotatate therapy in patients with progressive metastatic neuroendocrine tumors. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, Jun 03-07, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2022 Journal Article Factors that influence clinical trial participation by patients with cancer in Australia: a scoping review protocolYou, Kyung Ha, Lwin, Zarnie, Ahern, Elizabeth, Wyld, David and Roberts, Natasha (2022). Factors that influence clinical trial participation by patients with cancer in Australia: a scoping review protocol. BMJ open, 12 (4) e057675, e057675. doi: 10.1136/bmjopen-2021-057675 |
|
2022 Journal Article Scoping to analyze oncology trial participation in AustraliaYou, Kyung Ha, Ahern, Elizabeth, Wyld, David, Lwin, Zarnie and Roberts, Natasha (2022). Scoping to analyze oncology trial participation in Australia. Seminars in Oncology, 49 (2), 178-181. doi: 10.1053/j.seminoncol.2022.04.003 |
|
2022 Journal Article The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosisGuccione, Lisa, Gough, Karla, Drosdowsky, Allison, Price, Timothy, Pavlakis, Nick, Wyld, David, Ransom, David, Michael, Michael and Schofield, Penelope (2022). The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosis. Patient Education and Counseling, 105 (1), 212-220. doi: 10.1016/j.pec.2021.05.006 |
|
2021 Journal Article Equity across the cancer care continuum for culturally and linguistically diverse migrants living in Australia: a scoping reviewScanlon, Brighid, Brough, Mark, Wyld, David and Durham, Jo (2021). Equity across the cancer care continuum for culturally and linguistically diverse migrants living in Australia: a scoping review. Globalization and Health, 17 (1) 87, 87. doi: 10.1186/s12992-021-00737-w |
|
2021 Journal Article The effects of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2 pilot randomised controlled trialMolassiotis, Alex, Brown, Teresa, Cheng, Hui Lin, Byrnes, Angela, Chan, Raymond Javan, Wyld, David, Eastgate, Melissa, Yates, Patsy, Marshall, Andrea P, Fichera, Rebecca, Isenring, Liz, To, Ki Fung, Ko, Po Shan, Lam, Wang, Lam, Yuk Fong, Au, Lai Fan and Lo, Raymond See-kit (2021). The effects of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2 pilot randomised controlled trial. Nutrition Journal, 20 (1) 2, 2. doi: 10.1186/s12937-020-00657-2 |
|
2021 Journal Article Our experience of nursing/allied health practitioner led geriatric screening and assessment of older patients with cancer – a highly accessible model of careThaker, Darshit Arunbhai, McGuire, Peter, Bryant, Geoffrey, Wyld, David, Leach, Justine, Wheatley, Hermione, Snape-Jenkinson, Stella, Kelly, Bernadette, Bourke, Anne and Kennedy, Glen (2021). Our experience of nursing/allied health practitioner led geriatric screening and assessment of older patients with cancer – a highly accessible model of care. Journal of Geriatric Oncology, 12 (8), 1186-1192. doi: 10.1016/j.jgo.2021.05.003 |
|
2021 Journal Article Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumoursElston, Marianne S., Love, Amanda, Kevat, Dev, Carroll, Richard, Siow, Zhen Rong, Pattison, Sharon, Boyle, Veronica, Segelov, Eva, Strickland, Andrew H., Wyld, David, Gauci, Richard, Kennedy, Kim and Ransom, David (2021). Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours. Cancer Medicine, 10 (23), 8405-8411. doi: 10.1002/cam4.4345 |
|
2021 Journal Article Preclinical molecular PET-CT imaging targeting CDCP1 in colorectal cancerCuda, Tahleesa J., He, Yaowu, Kryza, Thomas, Khan, Tashbib, Tse, Brian W., Sokolowski, Kamil A., Liu, Cheng, Lyons, Nicholas, Gough, Madeline, Snell, Cameron E., Wyld, David K., Rose, Stephen, Riddell, Andrew D., Stevenson, Andrew R. L., Thomas, Paul A., Clark, David A., Puttick, Simon and Hooper, John D. (2021). Preclinical molecular PET-CT imaging targeting CDCP1 in colorectal cancer. Contrast Media and Molecular Imaging, 2021 3153278, 3153278. doi: 10.1155/2021/3153278 |
|
2021 Journal Article Prospective cohort study of an Australian cancer care services-led model of emergent careButton, Elise, Gavin, Nicole C., Bates, Tracey, Ahmed, Deka, Nasato, Gillian, Wyld, David, Kennedy, Glen, Fennelly, Eileen, Smith, Michael, Northfield, Sarah and Yates, Patsy (2021). Prospective cohort study of an Australian cancer care services-led model of emergent care. Australian Health Review, 45 (5), 613-621. doi: 10.1071/AH20346 |
|
2021 Conference Publication 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with somatostatin-expressing neuroendocrine tumors: a real-world retrospective review of efficacy and safety from an Australian tertiary cancer CenterNalder, Mark, Ladwa, Rahul, Raina, Anant, Burge, Matthew E., Love, Amanda, Pattison, David A., Ramsay, Stuart and Wyld, David (2021). 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with somatostatin-expressing neuroendocrine tumors: a real-world retrospective review of efficacy and safety from an Australian tertiary cancer Center. 2021 ASCO Annual Meeting I, Virtual, 4-8 June 2021. Alexandria, VA USA: American Society of Clinical Oncology. doi: 10.1200/jco.2021.39.15_suppl.e16198 |
|
2021 Journal Article Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, AustraliaGasper, Harry, Ahern, Elizabeth, Roberts, Natasha, Chan, Bryan, Hughes, Brett, Kennedy, Glen, Wyld, David, Eastgate, Melissa and Lwin, Zarnie (2021). Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia. BMJ Open, 11 (5) e044655, e044655. doi: 10.1136/bmjopen-2020-044655 |
|
2021 Journal Article Resilience and ongoing quality care for cancer clinical trials during COVID-19: experience from a tertiary hospital in AustraliaIves, Amy, Pusztai, Tricia, Keller, Jacqui, Ahern, Elizabeth, Chan, Bryan, Gasper, Harry, Wyld, David, Kennedy, Glen, Dickie, Graeme, Lwin, Zarnie and Roberts, Natasha A. (2021). Resilience and ongoing quality care for cancer clinical trials during COVID-19: experience from a tertiary hospital in Australia. Asia-Pacific Journal of Clinical Oncology, 18 (2), e141-e147. doi: 10.1111/ajco.13570 |
|
2021 Conference Publication P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumors (GCTs)Subramaniam, Shalini, Toner, Guy C., Stockler, Martin R., Martin, Andrew James, Pashankar, Farzana D., Tran, Ben, Jeffery, Mark, Mazhar, Danish, Huddart, Robert A., Walpole, Euan Thomas, Stevanovic, Amanda Gwendolyn, Wyld, David, Hanning, Fritha J., Wheater, Matthew James, Balagtas, Jay R., Troon, Simon, Birtle, Alison Jane, White, Jeff D. and Grimison, Peter S. (2021). P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumors (GCTs). ASCO Genitourinary Cancers Symposium (GU ASCO), Online, 11-13 February 2021. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2021.39.6_suppl.TPS390 |
|
2021 Journal Article Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): the NETPET score as a prognostic biomarkerChan, David L., Ulaner, Gary A., Pattison, David A., Wyld, David, Ladwa, Rahul, Kirchner, Julian, Li, Bob T, Lai, W Victoria, Pavlakis, Nick, Roach, Paul J and Bailey, Dale L (2021). Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): the NETPET score as a prognostic biomarker. Journal of Nuclear Medicine, 62 (9), 1278-1284. doi: 10.2967/jnumed.120.257659 |
|
2021 Journal Article Hemoglobin, body mass index, and age as risk factors for Paclitaxel- and Oxaliplatin-induced peripheral neuropathyMizrahi, David, Park, Susanna B., Li, Tiffany, Timmins, Hannah C., Trinh, Terry, Au, Kimberley, Battaglini, Eva, Wyld, David, Henderson, Robert D., Grimison, Peter, Ke, Helen, Geelan-Small, Peter, Marker, Julie, Wall, Brian and Goldstein, David (2021). Hemoglobin, body mass index, and age as risk factors for Paclitaxel- and Oxaliplatin-induced peripheral neuropathy. JAMA Network Open, 4 (2) e2036695, 1-14. doi: 10.1001/jamanetworkopen.2020.36695 |
|
2021 Journal Article Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015Wyld, David, Moore, Julie, Tran, Nancy and Youl, Philippa (2021). Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015. Asia-Pacific Journal of Clinical Oncology, 17 (4), 350-358. doi: 10.1111/ajco.13503 |
